Hemodynamic Parameters in Predicting Time to Clinical Worsening in Pulmonary Arterial Hypertension

被引：0
|
作者：
Kanwar, M. [1 ]
Kraisangka, J. [2 ]
Scott, J. [3 ]
Peter, A. [3 ]
Antaki, J. [4 ]
Benza, R. [5 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[2] Mahidol Univ, Mahidol, Thailand
[3] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA
[4] Cornell Univ, Ithaca, NY USA
[5] Ohio State Univ, Columbus, OH 43210 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2021年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
437
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [1] HEMODYNAMIC PARAMETERS IN PREDICTING SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION
    Scott, Jacqueline
    Lohmueller, Lisa
    Kraisangka, Jidapa
    Kanwar, Manreet
    Benza, Raymond
    CHEST, 2019, 156 (04) : 1173A - 1174A
  • [2] Hemodynamic Parameters in Predicting Survival in Pulmonary Arterial Hypertension
    Kanwar, M. K.
    Krainsangka, J.
    Scott, J.
    Barrett, T.
    Everett, A.
    Perer, A.
    Antaki, J.
    Benza, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S188 - S188
  • [3] A simple hemodynamic parameter to predict clinical worsening in pulmonary arterial hypertension
    Amin, Ahmad
    Mohamadifar, Arezoo
    Keshmiri, Mohammad Sadegh
    Ghadrdoost, Behshid
    Taghavi, Sepideh
    Naderi, Nasim
    JOURNAL OF CRITICAL CARE, 2017, 38 : 324 - 327
  • [4] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, R
    CHEST, 2005, 128 (04) : 160S - 161S
  • [5] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, RJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S167 - S167
  • [6] Endpoints in pulmonary arterial hypertension: the role of clinical worsening
    Peacock, Andrew
    Keogh, Anne
    Humbert, Marc
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 : S1 - S9
  • [7] Sitaxsentan improves time to clinical worsening (TCW) in patients with pulmonary arterial hypertension (PAH)
    Oudiz, R. J.
    Frost, A. E.
    Lawrence, E. C.
    Galie, N.
    Barst, R. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S75 - S75
  • [8] Sitaxsentan improves time to clinical worsening (TCW) in patients with pulmonary arterial hypertension (PAH)
    Oudiz, RJ
    Frost, AE
    Lawrence, EC
    Galie, N
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 307A - 307A
  • [9] Fluid challenge predicts clinical worsening in pulmonary arterial hypertension
    D'Alto, Michele
    Motoji, Yoshiki
    Romeo, Emanuele
    Argiento, Paola
    Di Marco, Giovanni Maria
    Iacono, Agostino Mattera
    D'Andrea, Antonello
    Rea, Gaetano
    Golino, Paolo
    Naeije, Robert
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 261 : 167 - 171
  • [10] Clinical worsening in trials of pulmonary arterial hypertension: results and implications
    Galie, Nazzareno
    Simonneau, Gerald
    Barst, Robyn J.
    Badesch, David
    Rubin, Lewis
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 : S11 - S19
12345